Pharmaceutical News

RSS

FDA-approved drug for lymphoma and leukemia may help treat common type of brain tumor

New Cleveland Clinic research shows for the first time that ibrutinib, an FDA-approved drug for lymphoma and leukemia, may also help treat the most common – and deadliest – type of brain tumor.

30 May 2018

Radiotherapy drug used for treating rare neuroendocrine cancers can be safe, effective for patients

A radiotherapy drug that treats the rare neuroendocrine cancers pheochromocytoma and paraganglioma can be both effective and safe for patients, according to the findings of a multi-center trial led by researchers in the Abramson Cancer Center of the University of Pennsylvania.

30 May 2018

Scientists develop a new approach for efficient cancer therapy

For efficient cancer therapy with few side effects, the active drug should selectively attain high concentration in the tumor.

30 May 2018

Bioethicist: 'Right to Try Act' will not benefit terminally-ill patients

Gregory Pence, Ph.D., professor and Chair of Philosophy, teaches bioethics at the University of Alabama at Birmingham.

26 May 2018

Princeton Instruments and C-SOPS announce collaboration on innovative pharmaceutical technology

Princeton Instruments and the Center for Structured Organic Particulate Systems are pleased to announce a six-month collaboration on a novel pharmaceutical technology that enables close monitoring and control of drug manufacturing processes.

From Teledyne Princeton Instruments 26 May 2018

UK steps forward to tackle global antimicrobial resistance

With 10 million people a year projected to die from antibiotic-resistant infections by 2050, it’s important that all partners, including the pharmaceutical industry, step up and work together to tackle this issue.

26 May 2018

Study finds early antibiotic initiation for majority of premature infants

Most premature infants, who are at risk for sepsis but who may not have a culture confirmation of infection, continue to receive early antibiotics in the first few days of life, a finding that suggests neonatal antibiotic stewardship efforts are needed to help clinicians identify infants at lowest risk for infection to avoid unnecessary antibiotic exposure.

25 May 2018

FDA approves novel enzyme therapy for adults with rare and serious genetic disease

The U.S. Food and Drug Administration today approved Palynziq (pegvaliase-pqpz) for adults with a rare and serious genetic disease known as phenylketonuria (PKU).

25 May 2018

Pfizer settles kickback case related to copay assistance for $24m

Pfizer will pay the government nearly $24 million as part of a settlement to resolve allegations that it funneled money through a foundation resulting in illegal kickbacks.

24 May 2018

Antidepressant treatments increase risk of weight gain, study finds

Researchers in the School of Population Health & Environmental Sciences have found that patients prescribed any of the 12 most commonly used antidepressants were 21% more likely to experience an episode of gain weight than those not taking the drugs, after adjusting for other factors which might affect this result.

24 May 2018

Skin cream containing rapamycin reduces TSC-related facial tumors

Addressing a critical issue for people with a genetic disorder called tuberous sclerosis complex, doctors at The University of Texas Health Science Center at Houston reported that a skin cream containing rapamycin significantly reduced the disfiguring facial tumors affecting more than 90 percent of people with the condition.

23 May 2018

Drugmakers blamed for blocking generics have milked prices and cost U.S. billions

Makers of brand-name drugs called out by the Trump administration for potentially stalling generic competition have hiked their prices by double-digit percentages since 2012 and cost Medicare and Medicaid nearly $12 billion in 2016, a Kaiser Health News analysis has found.

23 May 2018

Medication-related harm found to be common among older adults, but preventable

New research indicates that harm from medicines is common in older adults following hospital discharge, and it results in substantial use of healthcare resources.

23 May 2018

Unnecessary antibiotic use for asthma exacerbations linked to increased hospital stays, costs

Administering antibiotics to adults hospitalized with an asthma exacerbation without any documented indication of lung infection appears to lengthen hospital stay, increase cost and result in increased risk for antibiotic-related diarrhea, according to new research presented at the ATS 2018 International Conference.

23 May 2018

Celgene to share new and updated data around novel hematological therapies

Celgene Corporation today announced that data from a broad range of early and late stage studies evaluating Celgene investigational agents and investigational uses of marketed products will be presented at the 23rd European Hematology Association annual meeting in Stockholm, Sweden, from June 14-17, 2018.

22 May 2018

Pfizer starts Phase 1/2 study of RSV vaccine candidate in healthy adult volunteers

Pfizer Inc. today announced that it has started a Phase 1/2 trial of its respiratory syncytial virus (RSV) vaccine candidate in healthy adult volunteers. RSV is a common respiratory virus that affects the lungs and airways, with significant impact on young children and older adults.

22 May 2018

Celltrion Healthcare advocates early introduction of biologics for patients to improve clinical outcomes

At the International Society for Pharmacoeconomics and Outcomes Research 23rd Annual International Meeting in Baltimore, Celltrion Healthcare today advocated for healthcare systems to introduce biologics earlier in a patient’s treatment regimen in order to improve clinical outcomes.

22 May 2018

Eczema drug alleviates asthma symptoms and improves lung function

Two new studies of patients with difficult-to-control asthma show that the eczema drug dupilumab alleviates asthma symptoms and improves patients' ability to breathe better than standard therapies.

22 May 2018

PSCK9 inhibitors may provide benefit to atherosclerosis patients with high lipoprotein(a) levels

Lipoprotein(a) is a variant of LDL (low-density lipoprotein) cholesterol, and large amounts of data have shown that higher lipoprotein(a) levels are associated with an increased risk of cardiovascular events.

22 May 2018

FDA approves new drug to treat thrombocytopenia in adults with chronic liver disease

The U.S. Food and Drug Administration today approved Doptelet (avatrombopag) tablets to treat low blood platelet count (thrombocytopenia) in adults with chronic liver disease who are scheduled to undergo a medical or dental procedure. This is the first drug approved by the FDA for this use.

22 May 2018

Pharmaceutical News

FDA-approved drug for lymphoma and leukemia may help treat common type of brain tumor

Radiotherapy drug used for treating rare neuroendocrine cancers can be safe, effective for patients

Scientists develop a new approach for efficient cancer therapy

Bioethicist: 'Right to Try Act' will not benefit terminally-ill patients

Princeton Instruments and C-SOPS announce collaboration on innovative pharmaceutical technology

UK steps forward to tackle global antimicrobial resistance

Study finds early antibiotic initiation for majority of premature infants

FDA approves novel enzyme therapy for adults with rare and serious genetic disease

Pfizer settles kickback case related to copay assistance for $24m

Antidepressant treatments increase risk of weight gain, study finds

Skin cream containing rapamycin reduces TSC-related facial tumors

Drugmakers blamed for blocking generics have milked prices and cost U.S. billions

Medication-related harm found to be common among older adults, but preventable

Unnecessary antibiotic use for asthma exacerbations linked to increased hospital stays, costs

Celgene to share new and updated data around novel hematological therapies

Pfizer starts Phase 1/2 study of RSV vaccine candidate in healthy adult volunteers

Celltrion Healthcare advocates early introduction of biologics for patients to improve clinical outcomes

Eczema drug alleviates asthma symptoms and improves lung function

PSCK9 inhibitors may provide benefit to atherosclerosis patients with high lipoprotein(a) levels

FDA approves new drug to treat thrombocytopenia in adults with chronic liver disease

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Latest News